Tag: CDMO

Lonza bought Capsugel for $5.5 billion

lonza
Lonza, a Swiss biotechnology company, announced that following the receipt of all required regulatory approvals, it has completed the acquisition of Capsugel S.A.

Fujifilm Diosynth Biotechnologies completed its 100th pAVEway program

dna
Fujifilm Diosynth Biotechnologies, a leading global biologics Contract Development and Manufacturing Organisation, has announced the successful completion of its 100th program using its pAVEway™

Bristol-Myers Squibb sold its manufacturing facility to SK Biotek

bristol-myers-squibb
Bristol-Myers Squibb Company and SK Biotek Co., Ltd. today announced the companies have signed a definitive purchase agreement

Recipharm launched new GMP suite for manufacture of clinical trial material

clinical-trial-material
Recipharm, the contract development and manufacturing organisation (CDMO), has opened a newly built GMP suite for clinical trial material

Hovione announced the start of its first clinical trial

test-tube
Hovione announced the launch of its first clinical trial. Hovione will soon initiate recruitment for its Phase 1 clinical trial of HY02, a proprietary minocycline sterile ointment to treat a subset of ocular surface inflammation

Thermo Fisher Scientific will buy Patheon N.V.

thermo-fisher
Thermo Fisher Scientific Inc., the world leader in serving science and Patheon N.V., a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, announced that their boards of directors have approved the acquisition.

Saneca gets Russian cGMP certification

saneca
Contract development and manufacturing organisation (CDMO) Saneca Pharma has been granted a multiple dosage form approval for the manufacture and supply of solids, semi-solids and liquid finish dose products to Russia.

Generium selected Goodwin Biotechnology for optimization

generium
International Biotechnology Center "Generium", a private scientific research company in Russia that is committed to developing and delivering innovative, effective, and safe medical products and...

Fujifilm funded $130 million to its bioCDMO facilities

biotechnology
Fujifilm is investing $130 million to expand capacity at its U.S.- and U.K.-based BioCDMO (biopharma contract development manufacturing operation) facilities. Fujifilm established BioCDMO as a stan...